Arrhythmias and Electrophysiology

Supraventricular Tachycardia or Ventricular Tachycardia: An Unexpected Diagnostic Clue Novel RYR2-A4510T Variant Presenting Both as Autosomal Dominant and Autosomal Recessive Catecholaminergic Polymorphic Ventricular Tachycardia Long‐Term Outcomes With Class 1C Antiarrhythmic Drug Use in Atrial Fibrillation T-World Virtual Human Cardiomyocyte. II. Organ-Scale Simulations and Applications T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis Differential Impact of Low Voltage Area Radiofrequency Ablation on Recurrence of Atrial Fibrillation Versus Atrial Tachycardia in Patients With Persistent Atrial Fibrillation Optimal Ablation Strategies for Persistent Atrial Fibrillation With Heart Failure: Three-Year Follow-Up of a Prospective Multicenter Randomized Trial Expecting the Unexpected: Insights and Uncertainties From the ALTERRA Trial 3-Year Results Stimulant Toxicity as Acute-on-Chronic Cardiovascular Death: How Cardiovascular Care Needs to Adapt Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies